Finance

Beta
Lists
SXTP:NASDAQ
60 Degrees Pharmaceuticals Inc
$1.42
-7.19%
(-0.11) 1D
$1.45
+1.80% (+0.026)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SXTP...
Open
$1.54
High
$1.54
Low
$1.42
Mkt. cap
3.78M
Avg. vol.
58.21K
Volume
38.72K
52-wk high
$12.96
52-wk low
$1.29
EPS
-$10.47
Shares outstanding
2.66M
No. of employees
3
Open
$1.54
High
$1.54
Low
$1.42
Mkt. cap
3.78M
Avg. vol.
58.21K
Volume
38.72K
52-wk high
$12.96
52-wk low
$1.29
EPS
-$10.47
Shares outstanding
2.66M
No. of employees
3
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to SXTP in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for SXTP in the last 3 months.
Highest
Current $1.42
$3.70 (+160.56%)
Average
$3.70 (+160.56%)
Lowest
$3.70 (+160.56%)
News stories
From sources across the web
About 60 Degrees Pharmaceuticals Inc
CEO-
Employees3
Founded2010
Headquarters-
SectorPharmaceutical industry
Website60degreespharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
307.87K
528.56K
316.38K
162.09K
Cost of goods sold
299.94K
1.35M
759.56K
367.18K
Cost of revenue
299.94K
1.35M
759.56K
367.18K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.61M
1.51M
1.47M
1.89M
Operating expense
1.61M
1.51M
1.47M
1.89M
Total operating expenses
1.91M
2.85M
2.23M
2.26M
Operating income
-1.60M
-2.33M
-1.92M
-2.09M
Other non operating income
-127.38K
10.45K
479.57K
6.20K
EBT including unusual items
-1.73M
-2.32M
-1.44M
-2.09M
EBT excluding unusual items
-1.73M
-2.32M
-1.44M
-2.09M
Income tax expense
1.50K
250.00
-1.81K
-
Effective tax rate
-0.09%
-0.01%
0.13%
-
Other operating expenses
-
-
-
-
Net income
-1.73M
-2.32M
-1.44M
-2.09M
Net profit margin
-563.13%
-438.23%
-454.69%
-1,288.91%
Earnings per share
-4.33
-2.53
-8.17
-1.21
Interest and investment income
-
-
-
-
Interest expense
-1.22K
-1.71K
-3.09K
-1.39K
Net interest expenses
-1.22K
-1.71K
-3.09K
-1.39K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.59M
-2.30M
-1.89M
-2.07M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer